Incidence and Survival of Patients with Small Intestinal Neuroendocrine Tumours in a Danish NET Center
Open Access
- 1 January 2012
- journal article
- Published by Wiley in The Scientific World Journal
- Vol. 2012, 1-7
Abstract
Introduction. Small intestinal neuroendocrine tumours (NETs) have increased in incidence during the past decades. In recent years, new promising treatment modalities have been introduced. The aim of the present study was to characterize and compare patients with small intestinal NET seen in the periods 1994–2003 (group 1) and 2004–2011 (group 2) to demonstrate changes in incidence and survival in the two time periods.Patients and Methods. There were 52 NET patients in group 1 and 109 patients in group 2.Results. The incidence of small intestinal NET was 0.3/100.000/year in period 1 and 0.7/100.000/year in period 2. There was no difference in median chromogranin A levels (8709 versus 2381 pmol/L,), presence of liver metastases (56% versus 44%), clinical symptoms (flushing/diarrhea), or Ki67 index (2% versus 2%), between the two time periods. The 5-year survival rate in the two time periods was similar, 64.7%, and 77.0%, respectively, ().Conclusion. We observed an increase in the incidence of small intestinal NET during the period from January 1994 to December 2011, but we were not able to demonstrate an improved survival during the same time period.
Keywords
Funding Information
- Ipsen
- Novartis
- Novo Nordisk
This publication has 20 references indexed in Scilit:
- Trends of Incidence and Survival of Gastrointestinal Neuroendocrine Tumors in the United States: A Seer AnalysisJournal of Cancer, 2012
- Peptide Receptor Radionuclide Therapy with 90Y-DOTATOC and 177Lu-DOTATOC in Advanced Neuroendocrine Tumors: Results from a Danish Cohort Treated in SwitzerlandNeuroendocrinology, 2011
- The diversity and commonalities of gastroenteropancreatic neuroendocrine tumorsLangenbeck's Archives of Surgery, 2011
- Outcome of treating advanced neuroendocrine tumours with radiolabelled somatostatin analoguesClinical and Translational Oncology, 2009
- Small intestinal neuroendocrine tumors: Prognostic factors and survivalScandinavian Journal of Gastroenterology, 2009
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United StatesJournal of Clinical Oncology, 2008
- Description of patients with midgut carcinoid tumours: clinical database from a Danish centre.2007
- A 5‐decade analysis of 13,715 carcinoid tumorsCancer, 2003
- Epidemiology and survival in patients with carcinoid disease in the NetherlandsAnnals of Oncology, 2001
- Carcinoid tumors: Analysis of prognostic factors and survival in 301 patients from a referral centerAnnals of Oncology, 1997